Banca Mediolanum (BMED) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jan, 2026Executive summary
2024 was a record-breaking year with net income up 36% to €1.12 billion, driven by strong managed asset inflows, double-digit growth in all key metrics, and bold strategic execution.
Net inflows reached €10.44 billion (+46%), with managed assets up 17% to €138.5 billion.
Customer base expanded 7% to nearly 1.92 million, supported by promotional initiatives and network expansion.
Operating margin rose 11% to €1.09 billion, reflecting robust operational performance and a sustainable, fee-based business model.
Extraordinary performance fees of €370 million and a €2,000 bonus to all employees and Family Bankers significantly boosted results.
Financial highlights
Net commission income grew 13% to €1.17 billion; net interest income rose 8% to €811.1 million.
Cost-to-income ratio improved to 39%, reflecting higher efficiency; cost of risk stable at 18 basis points.
Loans granted totaled €3.1 billion, up 4%, with a net NPE ratio of 0.79%.
General insurance gross premiums increased 11% to €206.1 million.
Total assets under administration/management reached €138.5 billion, up 17% year-over-year.
Outlook and guidance
2025 guidance: net inflows into managed assets expected to match 2024's strong volumes, assuming normal market conditions.
Net interest income projected to decrease by 5% due to yield curve trends.
Cost-to-income ratio projected below 40%; cost of risk at 20 basis points.
Base dividend to increase, subject to shareholder approval.
CET1 ratio strengthening in anticipation of Basel III final terms in 2025.
Latest events from Banca Mediolanum
- Record net income, strong asset growth, and a 25% higher dividend highlight a standout year.BMED
Q4 20253 Feb 2026 - Net income up 24% to EUR 449.9M, assets under administration EUR 129.5B, CET1 at 23.7%.BMED
Q2 20242 Feb 2026 - Net income up 18% to €674.3M, with record assets and higher interim dividend.BMED
Q3 202415 Jan 2026 - Net income up 10% YoY, record inflows, and strong capital ratios support 2025 outlook.BMED
Q1 20258 Jan 2026 - Net income up 8% to €726M, assets at €150.4B, and interim dividend raised to €0.60/share.BMED
Q3 20258 Nov 2025 - Net income up 6% to €477.3M, with record assets, strong inflows, and robust capital ratios.BMED
Q2 20251 Nov 2025